Future advances in work-related asthma and the impact on occupational health

Occupational Medicine

Volumn 55, Issue 8, 2005, Pages 606-611

  Malo, Jean Luc ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Airway responsiveness; Occupational asthma

Indexed keywords

DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HUMAN; MEDICOLEGAL ASPECT; OCCUPATIONAL ASTHMA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL HEALTH; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SOCIOECONOMICS; SYMPTOM; WORKPLACE;

EID: 30744467707     PISSN: 09627480     EISSN: 14718405     Source Type: Journal    
DOI: 10.1093/occmed/kqi185     Document Type: Review

References (55)

1. Bernstein IL, Chan-Yeung M, Malo JL, Berstein D. Asthma in the Workplace, 2nd edn. New York: Marcel Dekker, 1999.
2. McDonald JC, Keynes HL, Meredith SK. Reported incidence of occupational asthma in the United Kingdom, 1989-97. Occup Environ Med 2000;57:823-829.
3. Blanc PD, Toren K. How much asthma can be attributed to occupational factors? Am J Med 1999;107:580-587.
4. Ameille J, Pauli G, Calastreng-Crinquand A et al. Reported incidence of occupational asthma in France, 1996-99. Occup Environ Med 2003;60:136-142.
5. Vandenplas O, Malo JL. Definitions and types of work-related asthma: A nosological approach. Eur Respir J 2003;21:706-712.
6. Pepys J, Bernstein IL. Historical aspects of occupational asthma. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, eds. Asthma in the Workplace, 2nd edn. New York: Marcel Dekker, 1999; 5-26.
7. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS); persistent asthma syndrome after high level irritant exposures. Chest 1985;88:376-384.
8. Das R, Blanc PD. Chlorine gas exposure and the lung: A review. Toxicol Ind Health 1993;9:439-455.
9. Gautrin D, Bernstein IL, Brooks S. Reactive airways dysfunction syndrome, or irritant-induced asthma. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, eds. Asthma in the Workplace. New York: Marcel Dekker, 1999; 565-593.
10. Mapp CE. The role of genetic factors in occupational asthma. Eur Respir J 2003;22:173-178.
11. Taylor AJ. HLA phenotype and exposure in development of occupational asthma. Ann Allergy Asthma Immunol 2003;90(Suppl. 2):24-27.
12. Lemière C, Romeo P, Chaboillez S, Tremblay C, Malo JL. Airway inflammation and functional changes after exposure to different concentrations of isocyanates. J Allergy Clin Immunol 2002;110:641-646.
13. Anees W, Huggins V, Pavord ID, Robertson AS, Burge PS. Occupational asthma due to low molecular weight agents: Eosinophilic and non-eosinophilic variants. Thorax 2002;57:231-236.
14. Maghni K, Lemière C, Ghezzo H, Yuquan W, Malo JL. Airway inflammation after cessation of exposure to agents causing occupational asthma. Am J Respir Crit Care Med 2004;169:367-372.
15. Braun-Fahrlander C, Riedler J, Herz U et al. Environmental exposure to endotoxin and its relation to asthma in school-age chidren. N Engl J Med 2002;347:869-877.
16. Pacheco KA, McCammon C, Liu AH et al. Airborne endotoxin predicts symptoms in non-mouse sensitized technicians and research scientists exposed to laboratory mice. Am J Respir Crit Care Med 2003;167:983-990.
17. Sastre J, Vandenplas O, Park HS. Pathogenesis of occupational asthma. Eur Respir J 2003;22:363-373.
18. Graham C, Rosenkranz HS, Karol MH. Structure-activity model of chemicals that cause human respiratory sensitization. Regul Toxicol Pharmacol 1997;26:296-306.
19. Agius RM. Why are some low-molecular-weight agents asthmagenic? Occup Med State Art Rev 2000;15:369-384.
20. Demnati R, Fraser R, Ghezzo H, Martin JG, Plaa G, Malo JL. Time-course of functional and pathological changes after a single high acute inhalation of chlorine in rats. Eur Respir J 1998;11:922-928.
21. Martin JG, Campbell HR, Iijima H et al. Chlorine-induced injury to the airways in the mouse. Am J Respir Crit Care Med 2003;168:568-574.
22. Heederik D. Are we closer to developing threshold limit values for allergens in the workplace? Curr Opin Allergy Clin Immunol 2001;1:185-189.
23. Beck LA, Yeung DY. Allergen sensitization through the skin induces systemic allergic responses. J Allergy Clin Immunol 20005;106:S258-S263.
24. Vandenplas O, Cartier A, Lesage J et al. Prepolymers of hexamethylene diisocyanate as a cause of occupational asthma. J Allergy Clin Immunol 1993;91:850-861.
25. Jajosky RAR, Harrison R, Reinisch F et al. Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments - California, Massachusetts, Michigan and New Jersey. Morb Mortal Wkly Rep 1999;48(SS-3):1-20.
26. Toren K, Brisman J, Olin AC, Blanc PD. Asthma on the job: Work-related factors in new-onset asthma and in exacerbations of pre-existing asthma. Respir Med 2000;94: 529-535.
27. Milton DK, Solomon GM, Rosiello RA, Herrick RF. Risk and incidence of asthma attributable to occupational exposure among HMO members. Am J Ind Med 1998; 33:1-10.
28. Malo JL, Chan Yeung M. Occupational asthma. J Allergy Clin Immunol 2001;108:317-328.
29. Tarlo SM. Liss GM. Can medical surveillance measures improve the outcome of occupational asthma? J Allergy Clin Immunol 2001;107:583-585.
30. Cullinan P, Tarlo S, Nemery B. The prevention of occupational asthma. Eur Respir J 2003;22:853-860.
31. Cathcart M, Nicholson P, Roberts D et al. Association for the Medical Subcommittee of the UK Soap and Detergent Industry. Enzyme exposure, smoking and lung function in employees in the detergent industry over 20 years. Occup Med (Lond) 1997;47:473-478.
32. Allmers H, Schmengler J, Skudlik C. Primary prevention of natural rubber latex allergy in the German health care system through education and intervention. J Allergy Clin Immunol 2002;110:318-323.
33. Tarlo SM, Liss GM. Diisocyanate-induced asthma: Diagnosis, prognosis, and effects of medical surveillance measures. Appl Occup Environ Hyg 2002;17:902-908.
34. Gautrin D, Infante-Rivard C, Dao TV, Magnan-Larose M, Desjardins D, Malo JL. Specific IgE-dependent sensitization, atopy and bronchial hyperresponsiveness in apprentices starting exposure to protein-derived agents. Am J Respir Crit Care Med 1997;155:1841-1847.
35. Gautrin D, Ghezzo H, Infante-Rivard C, Malo JL. Natural history of sensitization, symptoms and diseases in apprentices exposed to laboratory animals. Eur Respir J 2001; 17:904-908.
36. Malo JL, Ghezzo H, D'Aquino C, L'Archevêque J, Cartier A, Chan-Yeung M. Natural history of occupational asthma: Relevance of type of agent and other factors in the rate of development of symptoms in affected subjects. J Allergy Clin Immunol 1992;90:937-944.
37. Coppieters Y, Nemery B, Piette D. Étude bibliographique de l'efficacité des actions de prévention de l'asthme professionnel. Santé Publique 2003;15:423-435.
38. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333:107-112.
39. Burge PS, Moscato G. Physiologic assessment: Serial measurements of lung function. In: Bernstein IL, Chan-Yeung M, Malo JL, Bernstein DI, eds. Asthma in the Workplace, 2nd edn. New York: Marcel Dekker, 1999; 193-210.
40. Vandenplas O, Malo JL. Inhalation challenges with agents causing occupational asthma. Eur Respir J 1997;10: 2612-2629.
41. Malo JL, Lemière C, Desjardins A, Cartier A. Prevalence and intensity of rhinoconjunctivitis in subjects with occupational asthma. Eur Respir J 1997;10:1513-1515.
42. Girard F, Côté J, Boulet LP, Tarlo S, Hargreave FE, Lemière C. Role of induced sputum in the investigation of occupational asthma. Am J Respir Crit Care Med (in press).
43. Dewitte JD, Chan-Yeung M, Malo JL. Medicolegal and compensation aspects of occupational asthma. Eur Respir J 1994;7:969-980.
44. Gannon PFG, Weir DC, Robertson AS, Burge PS. Health, employment, and financial outcomes in workers with occupational asthma. Br J Ind Med 1993;50:491-496.
45. Ameille J, Parion JC, Bayeux MC et al. Consequences of occupational asthma on employment and financial status: A follow-up study. Eur Respir J 1997;10:55-58.
46. Larbanois A, Jamart J, Delwiche JP, Vandenplas O. Socioeconomic outcome of subjects experiencing asthma symptoms at work. Eur Respir J 2002;19:1107-1113.
47. Malo JL, Dewitte JD, Cartier A et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol 1993;91:1121-1127.
48. Ortega HG, Kreiss K, Schill DP, Weissman DN. Fatal asthma from powdering shark cartilage and review of fatal occupational asthma literature. Am J Ind Med 2002; 42:50-54.
49. Vandenplas O, Toren K, Blanc P. Health and socioeconomic impact of work-related asthma. Eur Respir J 2003;22:689-697.
50. Malo JL, Cartier A, Côté J et al. Influence of inhaled steroids on the recovery of occupational asthma after cessation of exposure: An 18-month double-blind cross-over study. Am J Crit Care Respir Med 1996;153:953-960.
51. Malo JL, Ghezzo H. Recovery of methacholine responsiveness after end of exposure in occupational asthma. Am J Respir Crit Care Med 2004;169:1304-1307.
52. Malo JL, Cartier A, Boulet LP et al. Bronchial hyperresponsiveness can improve while spirometry plateaus two to three years after repeated exposure to chlorine causing respiratory symptoms. Am J Respir Crit Care Med 1994;150:1142-1145.
53. Chan-Yeung M, Malo JL. Occupational asthma. Chest 1987;91:130S-136S.
54. American Thoracic Society. Guidelines for the evaluation of impairment/ disability in patients with asthma. Am Rev Respir Dis 1993;147:1056-1061.
55. American Medical Association. Asthma. In: Guides to the Evaluation of Permanent Impairment, 5 edn, 2001; 102-105.